| Literature DB >> 35113779 |
James Butler1, Sean D Kelly2, Katie J Muddiman2, Alexandros Besinis1,3, Mathew Upton2.
Abstract
Introduction. Cupriavidus pauculus is historically found in soil and water but has more recently been reported to cause human infection and death. Hospital sink traps can serve as a niche for bacterial persistence and a platform for horizontal gene transfer, with evidence of dissemination of pathogens in hospital plumbing systems driving nosocomial infection.Gap Statement. This paper presents the first C. pauculus strain isolated from a hospital sink trap. There are only six genome assemblies available on NCBI for C. pauculus; two of these are PacBio/Illumina hybrids. This paper presents the first ONT/Illumina hybrid assembly, with five contigs. The other assemblies available consist of 37, 38, 111 and 227 contigs. This paper also presents data on biofilm formation and lethal dose in Galleria mellonella; there is little published information describing these aspects of virulence.Aim. The aims were to identify the isolate found in a hospital sink trap, characterize its genome, and assess whether it could pose a risk to human health.Methodology. The genome was sequenced, and a hybrid assembly of short and long reads produced. Antimicrobial susceptibility was determined by the broth microdilution method. Virulence was assessed by measuring in vitro biofilm formation compared to Pseudomonas aeruginosa and in vivo lethality in Galleria mellonella larvae.Results. The isolate was confirmed to be a strain of C. pauculus, with a 6.8 Mb genome consisting of 6468 coding sequences and an overall G+C content of 63.9 mol%. The genome was found to contain 12 antibiotic resistance genes, 8 virulence factor genes and 33 metal resistance genes. The isolate can be categorized as resistant to meropenem, amoxicillin, amikacin, gentamicin and colistin, but susceptible to cefotaxime, cefepime, imipenem and ciprofloxacin. Clear biofilm formation was seen in all conditions over 72 h and exceeded that of P. aeruginosa when measured at 37 °C in R2A broth. Lethality in G. mellonella larvae over 48 h was relatively low.Conclusion. The appearance of a multidrug-resistant strain of C. pauculus in a known pathogen reservoir within a clinical setting should be considered concerning. Further work should be completed to compare biofilm formation and in vivo virulence between clinical and environmental strains, to determine how easily environmental strains may establish human infection. Infection control teams and clinicians should be aware of the emerging nature of this pathogen and further work is needed to minimize the impact of contaminated hospital plumbing systems on patient outcomes.Entities:
Keywords: Cupriavidus pauculus; Galleria mellonella; MF1; Sink trap; biofilm; whole genome sequencing
Mesh:
Substances:
Year: 2022 PMID: 35113779 PMCID: PMC8941954 DOI: 10.1099/jmm.0.001501
Source DB: PubMed Journal: J Med Microbiol ISSN: 0022-2615 Impact factor: 2.472
Genes of interest found within the MF1 draft genome
|
Gene type |
Gene name |
Gene product/function |
|---|---|---|
|
Antibiotic resistance genes |
|
β-lactamase |
|
|
RND multidrug efflux pump (AdeFGH) | |
|
|
Aminoarabinose transferase enzyme conferring colistin resistance | |
|
|
Class D β-lactamase | |
|
|
Cytoplasmic membrane component of the CeoAB-OpcM efflux pump | |
|
|
Multidrug efflux system | |
|
|
Regulates expression of multidrug exporter genes | |
|
|
Form an antibiotic efflux complex with TolC active against macrolides | |
|
|
Multidrug efflux system | |
|
|
Multidrug efflux system | |
|
Virulence factors |
|
Argininosuccinate synthase; arginine synthesis |
|
|
Chorismate synthase; aromatic amino acid synthesis | |
|
|
RNA chaperone at the post-transcriptional level | |
|
|
3-isopropylmalate dehydrogenase | |
|
|
Phosphoenolpyruvate synthase | |
|
|
DNA repair and maintenance | |
|
|
RNA polymerase sigma E; facilitates bacterial growth at high temperature and may facilitate persistence in macrophages | |
|
|
Anthranilate synthase component | |
|
Metal resistance genes |
|
Transmembrane arsenite transporter |
|
|
Methylarsenite oxidase; ferric reductase activity and protection from oxidative stress | |
|
|
Putative cobalt transporter subunit | |
|
|
Nickel and cobalt resistance | |
|
|
Cobalt chelatases involved in cobalamin synthesis, | |
|
|
Copper chaperone and sequestration, may also bind silver and cadmium | |
|
|
Na+-dependent Mg2+ transporter | |
|
|
Copper and silver resistance | |
|
|
Copper transport | |
|
|
Cadmium, zinc, and cobalt efflux | |
|
|
Mercury resistance | |
|
|
Components of molybdate uptake operon | |
|
|
Transcriptional regulator of the nikABCDE operon |
Listed are genes of interest found in the C. pauculus MF1 isolate whole genome, as annotated and highlighted by the PATRIC Comprehensive Genome Analysis tool using both CARD and PATRIC databases.
MICs of antibiotics against the MF1 isolate
|
Class |
Antibiotic |
MIC (µg ml−1) |
Classification ( |
Classification (PK-PD) |
|---|---|---|---|---|
|
Cephalosporins |
Cefotaxime |
1 |
|
Susceptible |
|
Ceftazidime |
8 |
Intermediate* |
Intermediate | |
|
Cefepime |
0.25 |
Intermediate* |
Susceptible | |
|
Carbapenems |
Meropenem |
>512 |
Resistant |
Resistant |
|
Imipenem |
0.5 |
Intermediate* |
Susceptible | |
|
Imipenem-Relebactam (2 : 1) |
0.25 |
Susceptible |
Susceptible | |
|
Penicillins |
Amoxicillin |
>512 |
|
Resistant |
|
Amoxicillin-Relebactam (16 : 1) |
16 |
|
| |
|
Amoxicillin-Clavulanate (5 : 1) |
64 |
|
Resistant | |
|
Aminoglycosides |
Gentamicin |
512 |
IE |
Resistant |
|
Amikacin |
512 |
Resistant |
Resistant | |
|
Fluoroquinolones |
Ciprofloxacin |
0.125 |
Intermediate* |
Susceptible |
|
Macrolides |
Erythromycin |
32 |
|
IE |
|
Tetracyclines |
Doxycycline |
0.25 |
|
IE |
|
Polymyxins |
Colistin |
16 |
Resistant |
IE |
MICs of antibiotics against the C. pauculus MF1 isolate and the resulting susceptibility/resistance classifications. Classifications according to the breakpoints for Pseudomonas spp. are given as well as classifications based on pharmacokinetic-pharmacodynamic data provided by EUCAST. ‘N/A’ indicates that a breakpoint is not available. ‘IE’ indicates that EUCAST report there is insufficient evidence to consider a particular agent as a therapy and give no breakpoint. Intermediate with an asterisk (*) indicates that an MIC breakpoint of S≤0.001 µg ml−1 is given as an ‘arbitrary off scale’ breakpoint by EUCAST. Where any set of results contained differences of more than one serial dilution step, the assays were repeated. Shown are the consensus (mode) results of three biological replicates; alternatively, the midpoint was used if the three results were within one serial dilution step of each other.
Fig. 1.Biofilm formation by MF1 (pink) and PAO1 (black) in R2A broth at either 37 °C (a)or 20 °C (b)and in TSB at either 37 °C (c)or 20 °C (d)over 72 h as determined by the CV solubilization assay. Data presented as mean±sd. **** P<0.0001, ** P<0.01, ns: not significant; two-way ANOVA with Šídák’s multiple comparisons test. Data presented are the average of n=3 biological replicates.